Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Disease
  4. /
  5. Craniopharyngioma

Craniopharyngioma

December 31, 2014January 25, 2020

Related News

  • Parabilis Medicines Announces Preliminary Clinical Data Showing Tumor
More News

Related Clinical Trial

  • Craniopharyngioma With Tumoral Hemorrhage
  • Neuromodulation for Hypothalamic Obesity
  • An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese
  • Weight Loss Study for Patients With Obesity Due to Craniopharyngioma o
  • Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary
More Clinical Trial

Related Disease

  • Craniopharyngioma
More Disease

Latest Research

  • 55-Year Follow-Up of the First Adult Patient With Craniopharyngioma Treated With Gamma Knife Radiosurgery
  • A 55-Year-Old Woman Presenting with a Second Diagnosis of Craniopharyngioma Following Diagnosis and Successful Treatment of Craniopharyngioma as a 5-Year-Old Child
  • A case report of obsessive-compulsive disorder in craniopharyngioma: Moderating effect of tumor
  • A fortunate bitten tongue-Hypothyroidism despite repeatedly normal plasma thyrotropin levels
  • A rare association of pheochromocytoma, paraganglioma, and pituitary adenoma (3PA): A case report and literature review
More Research
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo